B. Riley Reduces Earnings Estimates for National CineMedia

National CineMedia, Inc. (NASDAQ:NCMI) – Equities researchers at B. Riley decreased their Q4 2024 earnings per share (EPS) estimates for National CineMedia in a note issued to investors on Tuesday, November 5th. B. Riley analyst E. Wold now forecasts that the business services provider will earn $0.14 per share for the quarter, down from their prior estimate of $0.19. B. Riley has a “Buy” rating and a $8.50 price target on the stock. The consensus estimate for National CineMedia’s current full-year earnings is ($0.05) per share. B. Riley also issued estimates for National CineMedia’s Q2 2025 earnings at $0.05 EPS, Q4 2025 earnings at $0.28 EPS, FY2025 earnings at $0.21 EPS, Q1 2026 earnings at ($0.13) EPS, Q2 2026 earnings at $0.07 EPS, Q3 2026 earnings at $0.03 EPS and FY2026 earnings at $0.28 EPS.

National CineMedia (NASDAQ:NCMI) last released its quarterly earnings results on Tuesday, November 5th. The business services provider reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). National CineMedia had a return on equity of 3.50% and a net margin of 78.04%. The firm had revenue of $62.40 million for the quarter, compared to analyst estimates of $58.20 million. During the same quarter last year, the company earned $0.33 earnings per share.

A number of other research firms have also weighed in on NCMI. Wedbush reaffirmed a “neutral” rating and set a $7.50 price objective (up previously from $6.00) on shares of National CineMedia in a research report on Monday. Barrington Research increased their target price on National CineMedia from $7.50 to $8.25 and gave the company an “outperform” rating in a report on Wednesday. Finally, Benchmark restated a “buy” rating and issued a $8.00 price objective on shares of National CineMedia in a research note on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $8.06.

National CineMedia Stock Down 10.5 %

NASDAQ:NCMI opened at $6.53 on Thursday. National CineMedia has a 52 week low of $3.63 and a 52 week high of $7.39. The stock’s fifty day moving average is $6.88 and its two-hundred day moving average is $5.78. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $630.60 million, a price-to-earnings ratio of 2.44 and a beta of 2.07.

Institutional Investors Weigh In On National CineMedia

Hedge funds have recently added to or reduced their stakes in the company. SG Americas Securities LLC acquired a new stake in National CineMedia in the second quarter valued at about $56,000. Fermata Advisors LLC purchased a new position in National CineMedia in the second quarter valued at about $92,000. Bayesian Capital Management LP purchased a new position in National CineMedia in the first quarter valued at about $104,000. Oppenheimer Asset Management Inc. increased its holdings in National CineMedia by 38.9% in the first quarter. Oppenheimer Asset Management Inc. now owns 23,897 shares of the business services provider’s stock valued at $123,000 after buying an additional 6,690 shares in the last quarter. Finally, The Manufacturers Life Insurance Company purchased a new position in National CineMedia in the second quarter valued at about $124,000. Institutional investors and hedge funds own 69.49% of the company’s stock.

About National CineMedia

National CineMedia, Inc, through its subsidiary, National CineMedia, LLC, operates cinema advertising network in North America. It engages in the sale of advertising to national, regional, and local businesses in Noovie, a cinema advertising and entertainment show seen on movie screens; and sells advertising on its Lobby Entertainment Network, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theatre lobbies.